Metropolitan Life Insurance Company (MetLife)’s Guardant Health GH Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,181	Closed	-$128K	–	852
2024 Q1	$128K	Sell	6,181 -371	-6%	-$7.95K	0.01%	920
2023 Q4	$177K	Hold	6,552	–	–	0.01%	789
2023 Q3	$194K	Buy	6,552 +479	+8%	+$16.8K	0.01%	684
2023 Q2	$217K	Buy	+6,073	New	+$174K	0.01%	646
2022 Q1	–	Sell	-5,974	Closed	-$598K	–	2419
2021 Q4	$598K	Sell	5,974 -47	-0.8%	-$4.86K	0.01%	1304
2021 Q3	$753K	Sell	6,021 -198	-3%	-$23.5K	0.01%	1165
2021 Q2	$772K	Buy	6,219 +250	+4%	+$33.6K	0.01%	1204
2021 Q1	$911K	Sell	5,969 -268	-4%	-$40.5K	0.01%	1015
2020 Q4	$804K	Buy	6,237 +422	+7%	+$48.6K	0.01%	1034
2020 Q3	$650K	Sell	5,815 -85	-1%	-$7.78K	0.01%	1026
2020 Q2	$479K	Buy	5,900 +3,311	+128%	+$267K	0.01%	1237
2020 Q1	$180K	Sell	2,589 -82	-3%	-$6.29K	﹤0.01%	1652
2019 Q4	$209K	Sell	2,671 -22	-0.8%	-$1.58K	﹤0.01%	1895
2019 Q3	$172K	Sell	2,693 -2,054	-43%	-$181K	﹤0.01%	1984
2019 Q2	$410K	Hold	4,747	–	–	0.01%	1431
2019 Q1	$364K	Sell	4,747 -1,569	-25%	-$87K	0.01%	1498
2018 Q4	$237K	Buy	+6,316	New	+$233K	﹤0.01%	1692

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s GH Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Guardant Health (GH) in Q2 2024, closing a stake of 6,181 shares — an estimated $128K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in GH in Q4 2018 and held it in 17 quarters. The position peaked at $911K in Q1 2021. 282 funds tracked by Wall St. Rank hold GH as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Guardant Health position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 6,181 Guardant Health shares in Q2 2024, an estimated $128K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Guardant Health in Q4 2018 and held it in 17 quarters.
Metropolitan Life Insurance Company (MetLife)'s Guardant Health position peaked at $911K in Q1 2021.
282 funds tracked by Wall St. Rank held Guardant Health as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.